Rhon-klinikum Ag · XETR:RHK

Rhon-klinikum — FY2018 Earnings Presentation

10 slides from Rhon-klinikum's earnings presentation, Feb 22, 2019

  1. Slide 1: Preliminary Results for FY 2018

    Preliminary Results for FY 2018 22 February 2019 Stephan Holzinger Julian Schmitt RHÖN-KLINIKUM AG - Preliminary Results of 2017 - as of February 23, 2018

  2. Slide 2: Disclaimer

    Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any

  3. Slide 3: Highlights of FY 2018

    Highlights of FY 2018 “Against the industry trend, RHÖN-KLINIKUM AG continued to develop successfully in 2018, despite major regulatory hurdles, thanks to its strategic focus.”  First inter-sectoral Campus opened at Bad Neustadt last December  New separate accounting contract became effective  +€

  4. Slide 4: Strategic business development “THE NEW RHÖN”

    Strategic business development “THE NEW RHÖN” Campus Expansion strategy strategy Unique cross-sectoral care model Domestic Campus rollout 1st Campus established at Bad Neustadt Business opportunities abroad ̴850k patients ̴17k employees Five locations Digitalisation Only privatised Te l e m e d i c

  5. Slide 5: Preliminary results FY 2018

    Preliminary results FY 2018* Volumes Revenues  +1.6% more treated patients +1.8% 1,232.9  Total number of cases 850,147 1,211.1  Reduced number of inpatient cases (-0.4%) outperformed by increased number of ambulatory treatments (+2.3%) FY 2017 FY 2018 in million € Earnings & Cash EBITDA +28.3% 1

  6. Slide 6: Outlook 2019

    Outlook 2019 GUIDANCE Group REVENUES € 1.30bn +/- 5% 2019 Group EBITDA € 117.5m to € 127.5m Assumptions and key levers*  +1.8% DRG price effect on group revenues  +2.8% DRG volume growth on group revenues after catalogue effect  Further growth from additional charges, elective services and outpat

  7. Slide 7: Financial calendar for FY 2019

    Appendix Financial calendar for FY 2019  22 February 2019 Preliminary results for financial year 2018 Conference call  29 March 2019 Publication of annual financial report 2018 Annual Press Conference  10 April 2019 Capital Markets Day (Campus Bad Neustadt)  3 May 2019 Publication of interim rep

  8. Slide 8: Price Regulation in 2019 at a Glance

    Appendix Price Regulation in 2019 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level  Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2019: +2.65%

  9. Slide 9: Shareholder base

    Appendix Shareholder base Shareholder Structure as of 31 December 2018, according to the most recent notifications of voting rights at that time 25.1% Asklepios 24.7%* 24.7% Free Float 5.2% 75.3% Landeskrankenhilfe Strategic Investors 5.4% 25.0% Ingeborg Münch B. Braun 14.6% Eugen Münch/HCM SE * Sha

  10. Slide 10: IR contact information

    Appendix IR contact information Contact Julian Schmitt Head of Investor Relations & Treasury tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG - Preliminary Results for FY 2018 10

Rhön-Klinikum — FY2018 Earnings Presentation on 6ix